Ecron Acunova GmbH, Germany has appointed Anders Malm as managing director in its Germany office. He assumes the responsibility for operations of Europe and North America. He joins with a management team consisting of Dr. Klaus Wiedey, managing director of EA Germany & chief executive officer Europe, and Klemens Schuette, managing director of New Business Opportunities.
Anders Malm joined Ecron Acunova in 2012 as managing director of Ecron Acunova A/S in Denmark with responsibility for the Nordic region. With his experience in managing an Oncology CRO in USA, he was made responsible for North American operation as chief executive officer of Acunova Life Sciences, Inc. Princeton, NJ.
With an M.Sc. from Cornell University and an MBA from Sweden, Malm brings 25 years of business experience, with 15 years in the CRO sector on both sides of Atlantic.
Speaking on the appointment, D A Prasanna, chairman of Ecron Acunova CRO (EA) said, that Malm brings extensive professional experience in clinical research services and network of customer relationship in Europe and US. With his experience, he will grow and transform Ecron Acunova services to effectively meet the changing needs of sponsors.
On his appointment, Malm said that with a highly trained staff in US, Europe and Asia, Ecron Acunova has a knowledge base which is unique for a CRO of our size. The company has a global reach, while at the same time we are small enough to take care of clients on a local basis. We will continue to serve existing clients and build close relations with biotech and smaller pharma companies for global as well as local services.